Vancomycin-resistant enterococci, colonizing the intestinal tract of patients in a university hospital in greece

Detalhes bibliográficos
Autor(a) principal: Metallidis,Simeon
Data de Publicação: 2006
Outros Autores: Chatzidimitriou,Maria, Tsona,Afroditi, Bisiklis,Alexandros, Lazaraki,Georgia, Koumentaki,Eleni, Gikas,Ahilleas, Alexiou-Daniel,Stela, Nikolaidis,Pavlos
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Infectious Diseases
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702006000300005
Resumo: OBJECTIVE: Determine the prevalence of Vancomycin-resistant enterococci (VRE) colonizing the intestinal tract of hospitalized patients and define risk factors. MATERIAL AND METHODS: A point prevalence survey of VRE fecal carriage was carried out among patients who stayed at a 600-bed teaching hospital for at least two days. Resistance to vancomycin was detected by the E-test method. Epidemiological data was recorded for all patients included in the study and was used for the risk factor analysis. RESULTS: A total of 128 patients hospitalized for at least two days were enrolled in this investigation. Thirty-nine patients (30.5%) were colonized with vancomycin-resistant enterococci. Twenty-three of the 39 strains were identified as Enterococcus faecium, 13 were identified as Enterococcus gallinarum and three strains as Enterococcus casseliflavus. The risk factors that were significantly associated with VRE colonization included length of hospital stay (13.2 days vs. 8.6 days), age (60.7 years vs. 47.7 years) and the presence of underlying malignancies (28.2% vs. 11.2%). An association was found between VRE colonization and the use of antimicrobials with anaerobic activity, such as metronidazole, piperacillin/tazobactam and imipenem. The use of vancomycin was associated with VRE colonization in the intensive care unit. CONCLUSIONS: VRE colonization must be monitored, and risk factors should be determined, because they are useful for screening hospitalized patients for VRE colonization in order to establish prevention and control measures.
id BSID-1_62dcae5d1a4fc88c42a281338f8bff45
oai_identifier_str oai:scielo:S1413-86702006000300005
network_acronym_str BSID-1
network_name_str Brazilian Journal of Infectious Diseases
repository_id_str
spelling Vancomycin-resistant enterococci, colonizing the intestinal tract of patients in a university hospital in greeceVancomycin-resistant enterococciinestinal tracthospitalized patientsOBJECTIVE: Determine the prevalence of Vancomycin-resistant enterococci (VRE) colonizing the intestinal tract of hospitalized patients and define risk factors. MATERIAL AND METHODS: A point prevalence survey of VRE fecal carriage was carried out among patients who stayed at a 600-bed teaching hospital for at least two days. Resistance to vancomycin was detected by the E-test method. Epidemiological data was recorded for all patients included in the study and was used for the risk factor analysis. RESULTS: A total of 128 patients hospitalized for at least two days were enrolled in this investigation. Thirty-nine patients (30.5%) were colonized with vancomycin-resistant enterococci. Twenty-three of the 39 strains were identified as Enterococcus faecium, 13 were identified as Enterococcus gallinarum and three strains as Enterococcus casseliflavus. The risk factors that were significantly associated with VRE colonization included length of hospital stay (13.2 days vs. 8.6 days), age (60.7 years vs. 47.7 years) and the presence of underlying malignancies (28.2% vs. 11.2%). An association was found between VRE colonization and the use of antimicrobials with anaerobic activity, such as metronidazole, piperacillin/tazobactam and imipenem. The use of vancomycin was associated with VRE colonization in the intensive care unit. CONCLUSIONS: VRE colonization must be monitored, and risk factors should be determined, because they are useful for screening hospitalized patients for VRE colonization in order to establish prevention and control measures.Brazilian Society of Infectious Diseases2006-06-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702006000300005Brazilian Journal of Infectious Diseases v.10 n.3 2006reponame:Brazilian Journal of Infectious Diseasesinstname:Brazilian Society of Infectious Diseases (BSID)instacron:BSID10.1590/S1413-86702006000300005info:eu-repo/semantics/openAccessMetallidis,SimeonChatzidimitriou,MariaTsona,AfroditiBisiklis,AlexandrosLazaraki,GeorgiaKoumentaki,EleniGikas,AhilleasAlexiou-Daniel,StelaNikolaidis,Pavloseng2006-09-18T00:00:00Zoai:scielo:S1413-86702006000300005Revistahttps://www.bjid.org.br/https://old.scielo.br/oai/scielo-oai.phpbjid@bjid.org.br||lgoldani@ufrgs.br1678-43911413-8670opendoar:2006-09-18T00:00Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)false
dc.title.none.fl_str_mv Vancomycin-resistant enterococci, colonizing the intestinal tract of patients in a university hospital in greece
title Vancomycin-resistant enterococci, colonizing the intestinal tract of patients in a university hospital in greece
spellingShingle Vancomycin-resistant enterococci, colonizing the intestinal tract of patients in a university hospital in greece
Metallidis,Simeon
Vancomycin-resistant enterococci
inestinal tract
hospitalized patients
title_short Vancomycin-resistant enterococci, colonizing the intestinal tract of patients in a university hospital in greece
title_full Vancomycin-resistant enterococci, colonizing the intestinal tract of patients in a university hospital in greece
title_fullStr Vancomycin-resistant enterococci, colonizing the intestinal tract of patients in a university hospital in greece
title_full_unstemmed Vancomycin-resistant enterococci, colonizing the intestinal tract of patients in a university hospital in greece
title_sort Vancomycin-resistant enterococci, colonizing the intestinal tract of patients in a university hospital in greece
author Metallidis,Simeon
author_facet Metallidis,Simeon
Chatzidimitriou,Maria
Tsona,Afroditi
Bisiklis,Alexandros
Lazaraki,Georgia
Koumentaki,Eleni
Gikas,Ahilleas
Alexiou-Daniel,Stela
Nikolaidis,Pavlos
author_role author
author2 Chatzidimitriou,Maria
Tsona,Afroditi
Bisiklis,Alexandros
Lazaraki,Georgia
Koumentaki,Eleni
Gikas,Ahilleas
Alexiou-Daniel,Stela
Nikolaidis,Pavlos
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Metallidis,Simeon
Chatzidimitriou,Maria
Tsona,Afroditi
Bisiklis,Alexandros
Lazaraki,Georgia
Koumentaki,Eleni
Gikas,Ahilleas
Alexiou-Daniel,Stela
Nikolaidis,Pavlos
dc.subject.por.fl_str_mv Vancomycin-resistant enterococci
inestinal tract
hospitalized patients
topic Vancomycin-resistant enterococci
inestinal tract
hospitalized patients
description OBJECTIVE: Determine the prevalence of Vancomycin-resistant enterococci (VRE) colonizing the intestinal tract of hospitalized patients and define risk factors. MATERIAL AND METHODS: A point prevalence survey of VRE fecal carriage was carried out among patients who stayed at a 600-bed teaching hospital for at least two days. Resistance to vancomycin was detected by the E-test method. Epidemiological data was recorded for all patients included in the study and was used for the risk factor analysis. RESULTS: A total of 128 patients hospitalized for at least two days were enrolled in this investigation. Thirty-nine patients (30.5%) were colonized with vancomycin-resistant enterococci. Twenty-three of the 39 strains were identified as Enterococcus faecium, 13 were identified as Enterococcus gallinarum and three strains as Enterococcus casseliflavus. The risk factors that were significantly associated with VRE colonization included length of hospital stay (13.2 days vs. 8.6 days), age (60.7 years vs. 47.7 years) and the presence of underlying malignancies (28.2% vs. 11.2%). An association was found between VRE colonization and the use of antimicrobials with anaerobic activity, such as metronidazole, piperacillin/tazobactam and imipenem. The use of vancomycin was associated with VRE colonization in the intensive care unit. CONCLUSIONS: VRE colonization must be monitored, and risk factors should be determined, because they are useful for screening hospitalized patients for VRE colonization in order to establish prevention and control measures.
publishDate 2006
dc.date.none.fl_str_mv 2006-06-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702006000300005
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1413-86702006000300005
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1413-86702006000300005
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
publisher.none.fl_str_mv Brazilian Society of Infectious Diseases
dc.source.none.fl_str_mv Brazilian Journal of Infectious Diseases v.10 n.3 2006
reponame:Brazilian Journal of Infectious Diseases
instname:Brazilian Society of Infectious Diseases (BSID)
instacron:BSID
instname_str Brazilian Society of Infectious Diseases (BSID)
instacron_str BSID
institution BSID
reponame_str Brazilian Journal of Infectious Diseases
collection Brazilian Journal of Infectious Diseases
repository.name.fl_str_mv Brazilian Journal of Infectious Diseases - Brazilian Society of Infectious Diseases (BSID)
repository.mail.fl_str_mv bjid@bjid.org.br||lgoldani@ufrgs.br
_version_ 1754209239422730240